Literature DB >> 18682315

Identification of copy number alterations and its association with pathological features in clear cell and papillary RCC.

Daisuke Matsuda1, Sok Kean Khoo, Aaron Massie, Masatsugu Iwamura, Jindong Chen, David Petillo, Bill Wondergem, Michael Avallone, Stephanie J Kloostra, Min-Han Tan, Julie Koeman, Zhongfa Zhang, Richard J Kahnoski, Shiro Baba, Bin Tean Teh.   

Abstract

We report and characterize the copy number alterations (CNAs) in 35 clear cell and 12 papillary renal cell carcinomas (RCC) using Affymetrix 100K SNP arrays. Novel gain and loss regions are identified in both subtypes. In addition, statistically significant CNA are detected and associated with the pathological features: VHL mutation status, tumor grades, and sarcomatoid component in clear cell RCC and in types 1 and 2 of papillary RCC. Florescence in situ hybridization confirmed the copy number gain in the transforming growth factor, beta-induced gene (TGFBI), which is a possible oncogene for clear cell RCC.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682315     DOI: 10.1016/j.canlet.2008.06.015

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  15 in total

1.  Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.

Authors:  Brendan D Looyenga; Kyle A Furge; Karl J Dykema; Julie Koeman; Pamela J Swiatek; Thomas J Giordano; Andrew B West; James H Resau; Bin T Teh; Jeffrey P MacKeigan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

2.  Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma.

Authors:  Reza Nejati; Shuanzeng Wei; Robert G Uzzo; Sahar Poureghbali; Jianming Pei; Jacqueline N Talarchek; Karen Ruth; Essel Dulaimi; Alexander Kutikov; Joseph R Testa; Tahseen Al-Saleem
Journal:  Clin Genitourin Cancer       Date:  2019-09-26       Impact factor: 2.872

3.  Combined classical cytogenetics and microarray-based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinoma.

Authors:  Jianming Pei; Madelyn M Feder; Tahseen Al-Saleem; Zemin Liu; Angen Liu; Gary R Hudes; Robert G Uzzo; Joseph R Testa
Journal:  Genes Chromosomes Cancer       Date:  2010-07       Impact factor: 5.006

4.  A Comprehensive Study of Progressive Cytogenetic Alterations in Clear Cell Renal Cell Carcinoma and a New Model for ccRCC Tumorigenesis and Progression.

Authors:  Zhongfa Zhang; Bill Wondergem; Karl Dykema
Journal:  Adv Bioinformatics       Date:  2010-07-05

5.  TGFBI expression is associated with a better response to chemotherapy in NSCLC.

Authors:  Marta Irigoyen; María J Pajares; Jackeline Agorreta; Mariano Ponz-Sarvisé; Elisabeth Salvo; María D Lozano; Ruben Pío; Ignacio Gil-Bazo; Ana Rouzaut
Journal:  Mol Cancer       Date:  2010-05-28       Impact factor: 27.401

6.  Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study.

Authors:  Kunpeng Liu; Yuan Ren; Lijuan Pang; Yan Qi; Wei Jia; Lin Tao; Zhengyan Hu; Jin Zhao; Haijun Zhang; Li Li; Haifeng Yue; Juan Han; Weihua Liang; Jianming Hu; Hong Zou; Xianglin Yuan; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01

7.  Genome-wide profiling of chromosomal alterations in renal cell carcinoma using high-density single nucleotide polymorphism arrays.

Authors:  Meng Chen; Yuanqing Ye; Hushan Yang; Pheroze Tamboli; Surena Matin; Nizar M Tannir; Christopher G Wood; Jian Gu; Xifeng Wu
Journal:  Int J Cancer       Date:  2009-11-15       Impact factor: 7.396

8.  CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma.

Authors:  Fiona E McRonald; Mark R Morris; Dean Gentle; Laura Winchester; Dilair Baban; Jiannis Ragoussis; Noel W Clarke; Michael D Brown; Takeshi Kishida; Masahiro Yao; Farida Latif; Eamonn R Maher
Journal:  Mol Cancer       Date:  2009-06-03       Impact factor: 27.401

Review 9.  Significance of chromosome 9p status in renal cell carcinoma: a systematic review and quality of the reported studies.

Authors:  Ismail El-Mokadem; John Fitzpatrick; Bhavan Rai; J Cunningham; Norman Pratt; Stewart Fleming; Ghulam Nabi
Journal:  Biomed Res Int       Date:  2014-04-30       Impact factor: 3.411

10.  Analyses of potential predictive markers and survival data for a response to sunitinib in patients with metastatic renal cell carcinoma.

Authors:  Juana Dornbusch; Aristeidis Zacharis; Matthias Meinhardt; Kati Erdmann; Ingmar Wolff; Michael Froehner; Manfred P Wirth; Stefan Zastrow; Susanne Fuessel
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.